Implementation of the Kidney Disease Improving Global Outcomes guidelines for the prevention of acute kidney injury after cardiac surgery: An international cohort survey.


Journal

European journal of anaesthesiology
ISSN: 1365-2346
Titre abrégé: Eur J Anaesthesiol
Pays: England
ID NLM: 8411711

Informations de publication

Date de publication:
01 06 2023
Historique:
medline: 4 5 2023
pubmed: 14 4 2023
entrez: 13 4 2023
Statut: ppublish

Résumé

Increasing evidence from randomised controlled trials supports the implementation of a six-measure care bundle proposed by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines in patients at high risk for acute kidney injury (AKI) to reduce its incidence after cardiac surgery. To assess compliance with the KDIGO bundle in clinical practice. Prospective observational multinational study. Six international tertiary care centres, from February 2021 to November 2021. Five hundred and thirty-seven consecutive patients undergoing cardiac surgery during a 1-month observational period. All patients were assessed for the postoperative implementation of the following measures: avoidance of nephrotoxic medication and radiocontrast agents whenever possible, strict glycaemic control, close monitoring of renal function, optimisation of haemodynamic and volume status and functional monitoring of haemodynamic status. The primary endpoint was the proportion of patients receiving fully compliant care. Secondary outcomes were occurrence of AKI and major adverse kidney event rate at day 30. The full care bundle was applied to 0.4% of patients. There was avoidance of nephrotoxic drugs in 15.6%, radiocontrast agents in 95.3% and hyperglycaemia in 39.6%. Close monitoring of urine output and serum creatinine was achieved in 6.3%, 57.4% underwent optimisation of volume and haemodynamic status, and 43.9% received functional haemodynamic monitoring. 27.2% developed AKI within 72 h after surgery. The average number of implemented measures was 2.6 ± 1.0 and did not differ between AKI or non-AKI patients ( P  = 0.854). Adherence with the KDIGO bundle was very low in cardiac surgery patients. Initiatives to improve guideline compliance might provide a strategy to mitigate the burden of AKI. www.drks.de DRKS00024204.

Sections du résumé

BACKGROUND
Increasing evidence from randomised controlled trials supports the implementation of a six-measure care bundle proposed by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines in patients at high risk for acute kidney injury (AKI) to reduce its incidence after cardiac surgery.
OBJECTIVE
To assess compliance with the KDIGO bundle in clinical practice.
DESIGN
Prospective observational multinational study.
SETTING
Six international tertiary care centres, from February 2021 to November 2021.
PATIENTS
Five hundred and thirty-seven consecutive patients undergoing cardiac surgery during a 1-month observational period.
INTERVENTIONS
All patients were assessed for the postoperative implementation of the following measures: avoidance of nephrotoxic medication and radiocontrast agents whenever possible, strict glycaemic control, close monitoring of renal function, optimisation of haemodynamic and volume status and functional monitoring of haemodynamic status.
MAIN OUTCOME MEASURES
The primary endpoint was the proportion of patients receiving fully compliant care. Secondary outcomes were occurrence of AKI and major adverse kidney event rate at day 30.
RESULTS
The full care bundle was applied to 0.4% of patients. There was avoidance of nephrotoxic drugs in 15.6%, radiocontrast agents in 95.3% and hyperglycaemia in 39.6%. Close monitoring of urine output and serum creatinine was achieved in 6.3%, 57.4% underwent optimisation of volume and haemodynamic status, and 43.9% received functional haemodynamic monitoring. 27.2% developed AKI within 72 h after surgery. The average number of implemented measures was 2.6 ± 1.0 and did not differ between AKI or non-AKI patients ( P  = 0.854).
CONCLUSION
Adherence with the KDIGO bundle was very low in cardiac surgery patients. Initiatives to improve guideline compliance might provide a strategy to mitigate the burden of AKI.
TRIAL REGISTRATION
www.drks.de DRKS00024204.

Identifiants

pubmed: 37052046
doi: 10.1097/EJA.0000000000001837
pii: 00003643-202306000-00006
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

418-424

Informations de copyright

Copyright © 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.

Références

Vervoort D, Meuris B, Meyns B, et al. Global cardiac surgery: access to cardiac surgical care around the world. J Thorac Cardiovasc Surg 2020; 159:987.e6–996.e6.
Zilla P, Yacoub M, Zühlke L, et al. Global unmet needs in cardiac surgery. Glob Heart 2018; 13:293–303.
Grams ME, Sang Y, Coresh J, et al. Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis 2016; 67:872–880.
Corredor C, Thomson R, Al-Subaie N. Long-term consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 2016; 30:69–75.
Hu J, Chen R, Liu S, et al. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 2016; 30:82–89.
Alshaikh HN, Katz NM, Gani F, et al. Financial impact of acute kidney injury after cardiac operations in the United States. Ann Thorac Surg 2018; 105:469–475.
Lagny M-G, Jouret F, Koch J-N, et al. Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrol 2015; 16:76.
Kellum JA, Lameire N, Aspelin P, et al. KDIGO Clinical Practice Guideline for acute kidney injury 2012. Kidney inter Suppl 2012; 2:1–138.
Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017; 43:1551–1561.
Engelman DT, Crisafi C, Germain M, et al. Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg 2020; 160:1235.e2–1246e2.
Göcze I, Jauch D, Götz M, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: the Prospective Randomized BigpAK Study. Ann Surg 2018; 267:1013–1020.
Zarbock A, Küllmar M, Ostermann M, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg 2021; 133:292–302.
Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery-associated acute kidney injury: the 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc 2018; 7.:e008834.
Leone M, Ragonnet B, Alonso S, et al. AzuRéa Group. Variable compliance with clinical practice guidelines identified in a 1-day audit at 66 French adult intensive care units. Crit Care Med 2012; 40:3189–3195.
Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015; 43:3–12.
Küllmar M, Weiß R, Ostermann M, et al. A multinational observational study exploring adherence with the kidney disease: improving global outcomes recommendations for prevention of acute kidney injury after cardiac surgery. Anesth Analg 2020; 130:910–916.
Green SA, Bell D, Mays N. Identification of factors that support successful implementation of care bundles in the acute medical setting: a qualitative study. BMC Health Serv Res 2017; 17:120.
Townsend SR, Phillips GS, Duseja R, et al. Effects of compliance with the early management bundle (SEP-1) on mortality changes among medicare beneficiaries with sepsis: a propensity score matched cohort study. Chest 2022; 161:392–406.
Jing Y, Yuan Z, Zhou W, et al. A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit. Front Med (Lausanne) 2022; 9:1005162.
Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for critically ill patients with the ABCDEF bundle: results of the ICU Liberation Collaborative in over 15,000 adults. Crit Care Med 2019; 47:3–14.
Rashid M, Curzen N, Kinnaird T, et al. Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP. Int J Cardiol 2020; 301:7–13.
Lindberg O, de Geer L, Chew MS. Nonadherence to antibiotic guidelines in patients admitted to ICU with sepsis is associated with increased mortality: a registry-based, retrospective cohort study. Eur J Anaesthesiol 2020; 37:113–120.
von Groote TC, Ostermann M, Forni LG, et al. PrevAKI Investigators. The AKI care bundle: all bundle components are created equal-are they? Intensive Care Med 2022; 48:242–245.
Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on acute kidney injury biomarkers from the Acute Disease Quality Initiative Consensus Conference: a consensus statement. JAMA Netw Open 2020; 3:e2019209.
Yamada T, Shojima N, Noma H, et al. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med 2017; 43:1–15.
Arya VK, Al-Moustadi W, Dutta V. Cardiac output monitoring - invasive and noninvasive. Curr Opin Crit Care 2022; 28:340–347.
London MJ, Moritz TE, Henderson WG, et al. Standard versus fiberoptic pulmonary artery catheterization for cardiac surgery in the department of veterans affairs. Anesthesiology 2002; 96:860–870.
Levy MM, Dellinger RP, Townsend SR, et al. Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38:367–374.

Auteurs

Christina Massoth (C)

From the Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Germany (CM, MK, MM, AZ), Department of Anaesthesiology, La Fe University and Polytechnic Hospital Valencia (APM), Department of Anaesthesiology, University Hospital Vall d ́Hebron Barcelona, Spain (SGS), Scientific Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia (EG, AI), Institute of Anaesthesiology and Pain Therapy, Heart and Diabetes Center Bad Oeynhausen, Ruhr- University (VvD), Department of Cardiac Anaesthesiology and Intensive Care Medicine, German Heart Center Berlin (SO, NR), Department of Cardiac Anaesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Germany (SO) and Department of Intensive Care Medicine, University Hospital Vall d'Hebron Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH